Interplay between PCOS and microbiome: The road less travelled

Area of Science:

• Reproductive Endocrinology
• Microbiome Research
• Metabolic Disorders

Background:

• Polycystic Ovarian Syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism, ovarian dysfunction, and metabolic disturbances.
• Its etiology is multifactorial, involving genetic and environmental influences, with increasing evidence pointing to the gut microbiome's role.
• Altered gut microbiota composition is observed in women with PCOS, potentially contributing to its diverse clinical manifestations.

Purpose of the Study:

• To explore the intricate relationship between the gut microbiome and Polycystic Ovarian Syndrome (PCOS).
• To investigate the potential of microbiota-mediated interventions for managing PCOS phenotypes.
• To highlight novel therapeutic avenues for PCOS based on microbiome modulation.

Main Methods:

• Review of current literature on PCOS and gut microbiome interactions.
• Analysis of studies investigating the impact of prebiotics, probiotics, synbiotics, and fecal microbiota transplantation (FMT) in PCOS.
• Evaluation of the effects of these interventions on metabolic, inflammatory, and hormonal profiles in PCOS patients.

Main Results:

• Significant variations in gut microbiota composition are linked to different PCOS features.
• Microbiota-targeted therapies demonstrate potential in restoring eubiosis and mitigating PCOS-related dysbiosis.
• These interventions have shown positive effects on improving metabolic parameters, reducing inflammation, and normalizing hormonal imbalances in women with PCOS.

Conclusions:

• The gut microbiome plays a crucial role in the pathogenesis and phenotypic expression of PCOS.
• Microbiota-mediated treatments offer a promising, novel strategy for managing PCOS and its associated complications.
• Further research is essential to fully elucidate the underlying mechanisms and optimize these therapeutic approaches for PCOS management.